ArticleClinical pharmacology and therapeutics2018

Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients.

Hanna Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.